It was shown that GnRH-III specifically binds to GnRH-Receptors (GnRH-Rs) on cancer cells, causing a direct anti-proliferative activity on many tumor types [18], while its endocrine activity is strongly reduced when compared to GnRH-I, both in vitro and in vivo [19,20]. Here, GNRH1 is linked to neoplasm.